POLYMYALGIA RHEUMATICA
Clinical trials for POLYMYALGIA RHEUMATICA explained in plain language.
Never miss a new study
Get alerted when new POLYMYALGIA RHEUMATICA trials appear
Sign up with your email to follow new studies for POLYMYALGIA RHEUMATICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for PMR sufferers: drug combo aims to reduce steroid use
Disease control Not yet recruitingThis study tests whether adding the drug sarilumab to a slow steroid taper helps adults with early polymyalgia rheumatica (PMR) achieve lasting remission. About 300 people aged 50 and older will receive either sarilumab or a placebo, along with a 52-week steroid reduction plan. T…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Rare arthritis link under investigation
Knowledge-focused Not yet recruitingThis study aims to see if people with a type of spinal arthritis (sacroiliitis or axial spondylarthritis) also have giant cell arteritis or polymyalgia rheumatica, two conditions that cause inflammation in blood vessels or muscles. Researchers will compare 10 patients who have bo…
Matched conditions: POLYMYALGIA RHEUMATICA
Sponsor: Hôpital NOVO • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC